Example: Heart Attack

Clinical Trials on Primary Hyperoxaluria Type 2

Total 9 results

NCT03847909

Active, not recruiting

A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2

Conditions: Primary Hyperoxaluria Type 1 (PH1); Primary Hyperoxaluria Type 2 (PH2); Kidney Diseases; Urologic Diseases; Genetic Disease
NCT04580420

Not yet recruiting

Safety & Efficacy of DCR-PHXC in Patients With PH1/2 and ESRD

Conditions: Primary Hyperoxaluria; Primary Hyperoxaluria Type 2; End Stage Renal Disease
NCT03198507

Completed

ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator

Conditions: Helicobacter Pylori Infection; Dyspepsia
NCT04042402

Enrolling by invitation

Long Term Extension Study in Patients With Primary Hyperoxaluria

Conditions: Primary Hyperoxaluria Type 1 (PH1); Primary Hyperoxaluria Type 2 (PH2); Kidney Diseases; Urologic Diseases; Genetic Disease
NCT00314379

Completed

Endothelial Function in a Sample Group of Patients From the ICARE Study

Conditions: Cardiovascular Diseases
NCT02706886

Completed

Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1

Conditions: Primary Hyperoxaluria Type 1 (PH1)
NCT02026388

Recruiting

Rare Kidney Stone Consortium Biobank

Conditions: Primary Hyperoxaluria; Dent Disease; APRT Deficiency; Cystinuria
NCT03350451

Active, not recruiting

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Patients With Primary Hyperoxaluria Type 1

Conditions: PH1; Primary Hyperoxaluria; RNAi Therapeutic; siRNA; AGT
NCT02340689

Completed

Primary Hyperoxaluria Mutation Genotyping/Phenotyping

Conditions: Primary Hyperoxaluria